These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 22880228
41. Correction and reporting of potassium results in haemolysed samples. Dimeski G, Clague AE, Hickman PE. Ann Clin Biochem; 2005 Mar; 42(Pt 2):119-23. PubMed ID: 15829120 [Abstract] [Full Text] [Related]
42. Pseudohyperkalemia: Three Cases and a Review of Literature. Saleh-Anaraki K, Jain A, Wilcox CS, Pourafshar N. Am J Med; 2022 Jul; 135(7):e150-e154. PubMed ID: 35398330 [Abstract] [Full Text] [Related]
43. Spurious elevation of serum potassium concentration measured in samples with thrombocytosis. Roccaforte V, Daves M, Alfreijat A, Riva M, Leitner M, Filippi S, Angaroni G, Montani F, Platzgummer S, Lippi G. Diagnosis (Berl); 2016 Jun 01; 3(2):71-74. PubMed ID: 29536889 [Abstract] [Full Text] [Related]
44. Comparison of two platelet count estimation methodologies for peripheral blood smears. Malok M, Titchener EH, Bridgers C, Lee BY, Bamberg R. Clin Lab Sci; 2007 Jun 01; 20(3):154-60. PubMed ID: 17691671 [Abstract] [Full Text] [Related]
45. Pseudohyperkalemia in chronic lymphocytic leukemia: phlebotomy sites and pneumatic tubes. Sindhu SK, Hix JK, Fricke W. Am J Kidney Dis; 2011 Feb 01; 57(2):354-5. PubMed ID: 21251549 [No Abstract] [Full Text] [Related]
46. Pseudohyperkalemia in Serum and Plasma: The Phenomena and Its Clinical Implications. Mahto M, Kumar M, Kumar S, Banerjee A. Indian J Clin Biochem; 2021 Apr 01; 36(2):235-238. PubMed ID: 33867716 [Abstract] [Full Text] [Related]
47. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome]. Zuk E. Ann Acad Med Stetin; 1998 Apr 01; 44():137-54. PubMed ID: 9857536 [Abstract] [Full Text] [Related]
48. Pseudohyperkalemia and platelet counts. Nijsten MW, de Smet BJ, Dofferhoff AS. N Engl J Med; 1991 Oct 10; 325(15):1107. PubMed ID: 1891016 [No Abstract] [Full Text] [Related]
49. Clinical Thresholds for Pseudohyperkalemia and Pseudonormokalemia in Patients with Thrombocytosis. Delgado JA, Lopez B, Morell-García D, Martínez-Morillo E, Antonieta Ballesteros M, Jiménez SA, Durán MA, Bauça JM. EJIFCC; 2022 Oct 10; 33(3):233-241. PubMed ID: 36447798 [Abstract] [Full Text] [Related]
50. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Clin Cancer Res; 2000 Aug 10; 6(8):3147-52. PubMed ID: 10955796 [Abstract] [Full Text] [Related]
51. Studies on the use of BD Vacutainer® SST II™ and RST™ in general practice: investigation of artefactual hyperkalaemia. Huyghe T, Buntinx F, Bruyninckx R, Besard V, Vunckx J, Church S, Byron K, Rosa R, Blanckaert N. Ann Clin Biochem; 2014 Jan 10; 51(Pt 1):30-7. PubMed ID: 23897107 [Abstract] [Full Text] [Related]
52. Platelet activation in myeloproliferative disorders. Cortelazzo S, Viero P, Barbui T. Thromb Haemost; 1981 Jun 30; 45(3):211-3. PubMed ID: 6169172 [Abstract] [Full Text] [Related]
53. Effect of blood collection tubes on the incidence of artifactual hyperkalemia on patient samples from an outreach clinic. Babic N, Zibrat S, Gordon IO, Lee CC, Yeo KT. Clin Chim Acta; 2012 Oct 09; 413(19-20):1454-8. PubMed ID: 22698439 [Abstract] [Full Text] [Related]
54. [Pseudo-hyperkalaemia in myeloproliferative diseases (author's transl)]. Fink M, Hiller E, Huhn D, Brunswicker F. Dtsch Med Wochenschr; 1979 Nov 16; 104(46):1639-41. PubMed ID: 291506 [Abstract] [Full Text] [Related]
55. Pseudohyperkalemia caused by essential thrombocythemia in a patient with chronic renal failure: A case report. Guo Y, Li HC. World J Clin Cases; 2020 Nov 06; 8(21):5432-5438. PubMed ID: 33269281 [Abstract] [Full Text] [Related]
56. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials. de Denus S, Tardif JC, White M, Bourassa MG, Racine N, Levesque S, Ducharme A. Am Heart J; 2006 Oct 06; 152(4):705-12. PubMed ID: 16996842 [Abstract] [Full Text] [Related]
57. Pseudohyperkalemia in extreme leukocytosis. Colussi G, Cipriani D. Am J Nephrol; 1995 Oct 06; 15(5):450-2. PubMed ID: 7503149 [Abstract] [Full Text] [Related]
58. Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia. Howard MR, Ashwell S, Bond LR, Holbrook I. J Clin Pathol; 2000 Feb 06; 53(2):105-9. PubMed ID: 10767824 [Abstract] [Full Text] [Related]
59. [Mean platelet volume (MPV) in Crohn's disease patients]. Douda T, Bures J, Rejchrt S, Kopácová M, Pecka M, Malý J. Cas Lek Cesk; 2006 Feb 06; 145(11):870-3. PubMed ID: 17168422 [Abstract] [Full Text] [Related]
60. Pseudohyperkalemia: Look before you treat. De Rosales AR, Siripala DS, Bodana S, Ahmed F, Kumbala DR. Saudi J Kidney Dis Transpl; 2017 Feb 06; 28(2):410-414. PubMed ID: 28352030 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]